Insights

Strategic Market Position Evidenze positions itself as a full value CRO with a global reach, offering a comprehensive suite of services beyond traditional CROs, which presents opportunities to partner in complex, international clinical trials requiring advanced strategic insights.

Technology Integration The company's adoption of advanced tech tools like Microsoft 365, ECharts, and security measures such as reCAPTCHA and HSTS indicates a focus on efficiency, data security, and innovative trial management, ideal for clients seeking tech-enabled solutions.

Growth Potential With revenue estimated between 10 and 25 million dollars and a relatively moderate employee base, Evidenze displays scalable growth opportunities for companies looking to expand their CRO partner network in the pharmaceutical trial sector.

Client Focus Evidenze's emphasis on optimizing trial costs and accelerating regulatory success suggests a strong value proposition for pharmaceutical companies aiming to improve their R&D efficiency and reduce time-to-market.

Market Alignment Given the dynamic landscape of pharmaceutical research and the increasing importance of comprehensive trial management, partnering with a full value CRO like Evidenze offers strategic advantages for companies targeting innovative and cost-effective clinical trial solutions.

Similar companies to Evidenze

Apex Innovations
$10M$25M

Evidenze Tech Stack

Evidenze uses 8 technology products and services including Open Graph, Microsoft 365, ECharts, and more. Explore Evidenze's tech stack below.

Open Graph
Content Management System
Microsoft 365
Email
ECharts
Javascript Graphics
X-XSS-Protection
Security
HSTS
Security
reCAPTCHA
Security
X-Content-Type-Options
Web & Portal Technology
Livewire
Web Frameworks

Media & News

Evidenze's Email Address Formats

Evidenze uses at least 2 format(s):

Evidenze Email Formats	Example	Percentage
F.Last@dynasolutions.com	J.Doe@dynasolutions.com	56%
First.Last@dynasolutions.com	John.Doe@dynasolutions.com	26%
First.L@dynasolutions.com	John.D@dynasolutions.com	14%
First.MiddleLast@dynasolutions.com	John.MichaelDoe@dynasolutions.com	2%
FirstLast@dynasolutions.com	JohnDoe@dynasolutions.com	2%
F.Last@evidenze.com	J.Doe@evidenze.com	64%
First@evidenze.com	John@evidenze.com	19%
FirstML@evidenze.com	JohnMD@evidenze.com	11%
First.Middle@evidenze.com	John.Michael@evidenze.com	6%

Frequently Asked Questions

What is Evidenze's official website and social media links?

Evidenze's official website is evidenze.com and has social profiles on LinkedIn.

What is Evidenze's NAICS code?

Evidenze's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Evidenze have currently?

As of January 2026, Evidenze has approximately 433 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Bioestadístico Senior: A. T.Biostatistics Director | Evidenze Clinical Research: N. P.Director: P. M. P.. Explore Evidenze's employee directory with LeadIQ.

What industry does Evidenze belong to?

Evidenze operates in the Pharmaceutical Manufacturing industry.

What technology does Evidenze use?

Evidenze's tech stack includes Open GraphMicrosoft 365EChartsX-XSS-ProtectionHSTSreCAPTCHAX-Content-Type-OptionsLivewire.

What is Evidenze's email format?

Evidenze's email format typically follows the pattern of F.Last@dynasolutions.com. Find more Evidenze email formats with LeadIQ.

When was Evidenze founded?

Evidenze was founded in 1999.

Evidenze

Q: What is Evidenze's official website and social media links?

Evidenze's official website is evidenze.com. Evidenze has social profiles on LinkedIn.

Q: How many employees does Evidenze have currently?

Evidenze has approximately 433 employees.

Q: What technology does Evidenze use?

Evidenze's tech stack includes X-XSS-Protection, X-Content-Type-Options, Laravel, Cloudflare, ECharts.

Pharmaceutical ManufacturingCommunity of Madrid, Spain201-500 Employees

Evidenze is more than a full service CRO, is a full value CRO with Global reach.
Unlike traditional 'full-service' CROs, we go beyond execution.
Our 'Full Value' approach combines deep expertise, cutting-edge technology, and strategic insights to accelerate your trials, optimize costs, and ensure regulatory success.